Cardiff Oncology (Germany) Analysis
Cardiff Oncology is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cardiff Oncology stock analysis is to determine its intrinsic value, which is an estimate of what Cardiff Oncology is worth, separate from its market price. There are two main types of Cardiff Oncology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cardiff Oncology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cardiff Oncology's stock to identify patterns and trends that may indicate its future price movements.
The Cardiff Oncology stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Cardiff Oncology is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day, GermanUnityDay. Cardiff Stock trading window is adjusted to Europe/Berlin timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cardiff Oncology's ongoing operational relationships across important fundamental and technical indicators.
Cardiff |
Cardiff Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.57. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Cardiff Oncology recorded a loss per share of 0.81. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 20th of February 2019. Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. CARDIFF ONCOLOG operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11 people. For more information please call Thomas Adams at 858 952 7570 or visit https://www.cardiffoncology.com.Cardiff Oncology Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cardiff Oncology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cardiff Oncology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Cardiff Oncology is not yet fully synchronised with the market data | |
| Cardiff Oncology has some characteristics of a very speculative penny stock | |
| Cardiff Oncology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 359 K. Net Loss for the year was (28.29 M) with loss before overhead, payroll, taxes, and interest of (17.02 M). | |
| Cardiff Oncology has accumulated about 140.05 M in cash with (23.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54. |
Cardiff Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 77.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cardiff Oncology's market, we take the total number of its shares issued and multiply it by Cardiff Oncology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.About Cardiff Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardiff Oncology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardiff shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardiff Oncology. By using and applying Cardiff Stock analysis, traders can create a robust methodology for identifying Cardiff entry and exit points for their positions.
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California. CARDIFF ONCOLOG operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 11 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cardiff Oncology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as various price indices. Note that the Cardiff Oncology information on this page should be used as a complementary analysis to other Cardiff Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Tools for Cardiff Stock
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |